SFX by Ex Libris Inc.

Title:	Chemical biology. A small-molecule inhibitor of the aberrant transcription factor CBFbeta-SMMHC delays leukemia in mice
Source:	Science [0036-8075] Illendula, A yr:2015

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Jendza, K. "A small-molecule inhibitor of C5 complement protein." Nature chemical biology. 15.7: 666-668.
description	2.	Vander Heiden, Brian M. "SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance." Nature 520.7547 (2015): 363-367.
description	3.	Kikuchi, S. "Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myeloma." Leukemia 29.9 (2015): 1918-27.
description	4.	Das, Deepika S. "Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells." Clinical cancer research 23.15 (2017): 4280-432.
description	5.	Obenauf, Anna C. "Therapy-induced tumour secretomes promote resistance and tumour progression." Nature 520.7547 (2015): 368-372.
description	6.	Young, D. "On the sociology of Mycobacterium tuberculosis." Tuberculosis 94.6 (2014): 535-537.
description	7.	Mateos, M. "Effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib-melphalan-prednisone in the phase III VISTA study." American journal of hematology 90.4 (2015): 314-9.
description	8.	Dimopoulos, Meletios A. "Current treatment landscape for relapsed and/or refractory multiple myeloma." Nature Reviews Clinical Oncology 12.1 (2014): 42-54.
description	9.	Chouchani, Edward T. "Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS." Nature 515.7527 (2014): 431-5.
description	10.	Lobera, M. "Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group." Nature chemical biology 9.5 (2013): 319-325.
description	11.	Brenner, M K. "Will T-cell therapy for cancer ever be a standard of care?" Cancer gene therapy 19.12 (2012): 818-821.
description	12.	Meares, John P. "IRE1-dependent activation of AMPK in response to nitric oxide." Molecular and cellular biology 31.21 (2011): 4286-4297.
description	13.	CHAKRABARTI, A. "PERMEABILITY OF MEMBRANES TO AMINO-ACIDS AND MODIFIED AMINO-ACIDS - MECHANISMS INVOLVED IN TRANSLOCATION." Amino acids 6.3 (1994): 213-229.
description	14.	Killock, D. "Cell signalling: Cancer's vast secretes revealed—secretome changes promote resistance to therapy." Nature Reviews Clinical Oncology 12.6 (2015): 309-309.
description	15.	Premi, S. "Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure." Science 327.6224 (2015): 842-847.
description	16.	Shema, R. "Synthetic lethal screening in the mammalian central nervous system identifies Gpx6 as a modulator of Huntington's disease." Proceedings of the National Academy of Sciences of the United States of America 112.1 (2014): 268-72.
description	17.	O'Neill, Luke A J A. "Biochemistry: succinate strikes." Nature 515.7527 (2014): 350-1.
description	18.	Boon, Reinier A. "MicroRNA-34a regulates cardiac ageing and function." Nature 495.7439 (2013): 107-110.
description	19.	Zhu, Y. "USP14 de-ubiquitinates vimentin and miR-320a modulates USP14 and vimentin to contribute to malignancy in gastric cancer cells." Oncotarget 8.30 (2016): 48725-48736.
description	20.	E, Amengual E. "Mechanisms of Acquired Drug Resistance to the HDAC6 Selective Inhibitor Ricolinostat Reveals Rational Drug-Drug Combination with Ibrutinib." Clinical cancer research 23.12 (2016): 3084-3096.